AddLife AB (publ) ALIF-B.ST
Nasdaq Stockholm · Healthcare · Medical Instruments & Supplies
184.10 SEK
−0.6%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for AddLife
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 9,084 | 9,685 | 10,286 | 10,442 |
| EBITDA | 1,437 | 1,534 | 1,517 | 1,783 |
| Net income | 480 | 190 | 252 | 560 |
| Balance sheet | ||||
| Equity | 4,968 | 4,958 | 5,306 | 5,443 |
| Total debt | 5,591 | 5,289 | 5,072 | 4,774 |
| Cash | 376 | 272 | 331 | 813 |
| Net debt | 5,215 | 5,017 | 4,741 | 3,961 |
| Ratios and per share | ||||
| EBITDA margin | 15.8% | 15.8% | 14.7% | 17.1% |
| Profit margin | 5.3% | 2.0% | 2.4% | 5.4% |
| Return on equity | 9.7% | 3.8% | 4.7% | 10.3% |
| Earnings/share (SEK) | 3.94 | 1.56 | 2.07 | 4.60 |
| Book value/share (SEK) | 40.78 | 40.69 | 43.54 | 44.66 |
| Shares outstanding (M) | 122 | 122 | 122 | 122 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 40.1 |
| P/B | 4.1 |
| EV / EBITDA | 14.8 |
| Net debt / EBITDA | 2.2 |
| Return on equity | 10.3% |
| Profit margin | 5.4% |
| Beta 1Y | 0.99 |
| Revenue growth 1Y | +1.5% |
| Revenue CAGR 3Y | +4.8% |
| Earnings/share CAGR 3Y | +5.3% |
| ROE avg. 3Y | 6.3% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 1.50 |
| 2025 | 0.75 |
| 2024 | 0.50 |
| 2022 | 2.00 |
Not investment advice. Figures may contain errors from the data source.